These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 17908161

  • 1. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M, Wiklund O, Mattsson Hultén L, Persson A, Karlsson T, Herlitz J, Caidahl K.
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [Abstract] [Full Text] [Related]

  • 2. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B.
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes.
    Hartford M, Wiklund O, Hultén LM, Persson A, Karlsson T, Herlitz J, Hulthe J, Caidahl K.
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2039-46. PubMed ID: 20689079
    [Abstract] [Full Text] [Related]

  • 4. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M, Wiklund O, Mattsson Hultén L, Perers E, Person A, Herlitz J, Hurt-Camejo E, Karlsson T, Caidahl K.
    Int J Cardiol; 2006 Mar 22; 108(1):55-62. PubMed ID: 16516698
    [Abstract] [Full Text] [Related]

  • 5. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P.
    Biol Psychiatry; 2007 Aug 15; 62(4):302-8. PubMed ID: 17210140
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2339-46. PubMed ID: 18549920
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034
    [Abstract] [Full Text] [Related]

  • 8. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.
    Circulation; 2009 Jun 30; 119(25):3181-8. PubMed ID: 19528340
    [Abstract] [Full Text] [Related]

  • 9. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T, Ludlam CA, Riemermsa RA, Fox KA.
    Eur Heart J; 2001 Jul 30; 22(14):1226-34. PubMed ID: 11440495
    [Abstract] [Full Text] [Related]

  • 10. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec 30; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 11. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, CAPTURE Study Investigators.
    Circulation; 2003 Apr 29; 107(16):2109-14. PubMed ID: 12668510
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH.
    Am J Cardiol; 2006 Jun 15; 97(12):1697-701. PubMed ID: 16765116
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B, Ding S, Pu J, Liu JP, Song W, Du YP, Shen JY, Jin SX, Sun Y, Shen L.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr 15; 34(4):349-52. PubMed ID: 16776932
    [Abstract] [Full Text] [Related]

  • 14. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
    Kiliç T, Ural E, Oner G, Sahin T, Kiliç M, Yavuz S, Kanko M, Kahraman G, Bildirici U, Berki KT, Ural D.
    Anadolu Kardiyol Derg; 2009 Aug 15; 9(4):280-9. PubMed ID: 19666429
    [Abstract] [Full Text] [Related]

  • 15. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, Hall AS, EMMACE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2061-7. PubMed ID: 18021874
    [Abstract] [Full Text] [Related]

  • 16. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK, Morrow DA, Shui A, Rifai N, Cannon CP.
    Am J Cardiol; 2006 Oct 01; 98(7):861-5. PubMed ID: 16996863
    [Abstract] [Full Text] [Related]

  • 17. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW, Seidelin PH, Natarajan MK, Cohen EA, Strauss BH.
    Eur Heart J; 2004 Jun 01; 25(12):1029-35. PubMed ID: 15191773
    [Abstract] [Full Text] [Related]

  • 18. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2422-9. PubMed ID: 18565400
    [Abstract] [Full Text] [Related]

  • 19. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J, Hellmann I, Maass M, Giannitsis E, Dalhoff K, Katus HA.
    Herz; 2004 Dec 24; 29(8):795-801. PubMed ID: 15599677
    [Abstract] [Full Text] [Related]

  • 20. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E.
    Arterioscler Thromb Vasc Biol; 2009 Mar 24; 29(3):424-30. PubMed ID: 19122170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.